The Gentian NT-proBNP assay is an in vitro diagnostic assay for the quantitative measurement of N-terminal pro-brain natriuretic peptide (NT-proBNP).
Gentian's proprietary antibody and nanoparticle-based technology allows measurement of a low-concentration NT-proBNP on fast, cost-effective and high-volume clinical analysers with no biotin interference.
This test fulfils the need for accurate and rapid diagnosis of cardiac diseases to improve patient outcomes, and at the same time improves the laboratory productivity.
Want to know more about our NT-proBNP immunoassay launching in 2022? Please send us an email to email@example.com or fill out the form below and the Product Manager for NT-proBNP will get in touch: